OPERA - Trademark Details
Status: 730 - First Extension - Granted
Serial Number
90171690
Word Mark
OPERA
Status
730 - First Extension - Granted
Status Date
2021-11-30
Filing Date
2020-09-10
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-04-13
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
JACKSON, STEVEN W
Statements
Goods and Services
Oligonucleotide compounds being a component in pharmaceutical preparations for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; RNA compounds being a component in pharmaceutical preparations for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; RNA therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Nucleic acid therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Oligonucleotide compounds being a component in pharmaceutical preparations for use in RNA editing; Oligonucleotide compounds being a component in pharmaceutical preparations for use in base editing; Oligonucleotide compounds being a component in pharmaceutical preparations for use as RNA therapeutic for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Oligonucleotide compounds that facilitate the editing of RNA base; Pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; pharmaceuticals, namely, bio-pharmaceutical preparations for the treatment of rare diseases
Goods and Services
Custom manufacture of oligonucleotides or RNAs for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders
Goods and Services
Research and development of pharmaceutical products; research and development in the field of bioscience; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders; research and development of pharmaceutical preparations for the treatment of liver-based disorders, eye disorders and CNS disorders; research and development of oligonucleotide compounds for targeted RNA editing; research and development of oligonucleotide drug platforms for use in the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-10-16
Primary Code
005
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2020-10-16
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-10-16
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Rachelle A. Dubow
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0106304
Original Filing Date USPTO
2021-03-10
International Registration Number
1585579
International Registration Date
2021-03-10
International Status Code
480
International Renewal Date
2031-03-10
| Madrid History Events | ||
| Date | Code | Description |
| 2021-03-10 | ACERT | AUTOMATICALLY CERTIFIED |
| 2021-03-10 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2021-03-10 | APPST | IR CERTIFIED AND SENT TO IB |
| 2021-04-09 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
| 2021-10-21 | ADDCH | CHANGE OF ADDRESS RECEIVED FROM IB |
Trademark Events
| Event Date | Event Description |
| 2020-09-14 | NEW APPLICATION ENTERED IN TRAM |
| 2020-10-16 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2021-01-21 | ASSIGNED TO EXAMINER |
| 2021-01-28 | NON-FINAL ACTION WRITTEN |
| 2021-01-28 | NON-FINAL ACTION E-MAILED |
| 2021-01-28 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-03-09 | EXAMINERS AMENDMENT -WRITTEN |
| 2021-03-09 | EXAMINERS AMENDMENT E-MAILED |
| 2021-03-09 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2021-03-09 | ASSIGNED TO LIE |
| 2021-03-09 | EXAMINER'S AMENDMENT ENTERED |
| 2021-03-09 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-03-10 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-03-10 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-03-11 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-03-24 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-04-13 | PUBLISHED FOR OPPOSITION |
| 2021-04-13 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-06-08 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2021-11-30 | TEAS EXTENSION RECEIVED |
| 2021-11-30 | EXTENSION 1 FILED |
| 2021-11-30 | EXTENSION 1 GRANTED |
| 2021-12-02 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
